# Fresenius share sale and capital allocation

> Live situation record from CLSTR: https://clstr.news/situations/fresenius-share-sale-and-capital-allocation
> Updated: 2026-09-07T13:42:01.000Z. Sources: 4. Developments: 2.

Fresenius SE & Co. KGaA announced an agreement to sell approximately 7.8 million shares of Fresenius Medical Care to selected institutional investors. The transaction, valued at roughly €300 million, represents about 2.9 percent of the dialysis provider’s issued share capital.

Following the sale, Fresenius will retain a 25 percent stake in Fresenius Medical Care. The company plans to use the net proceeds to reduce group net debt and increase strategic flexibility for its ‘#FutureFresenius’ transformation. Fresenius expects to report a book gain in the low to mid-double-digit millions of euros as a special item in the third quarter.

## Timeline

### 2026-09-07: Fresenius and Gerresheimer report significant share acquisitions

Michael Sen of Fresenius SE & Co. KGaA and Active Ownership Opportunities SCS have both reported significant share acquisitions in their respective companies.

2 sources. https://clstr.news/cluster/fresenius-and-gerresheimer-report-significant-share-acquisitions

### 2026-08-20: Fresenius to sell €300 million in Fresenius Medical Care shares

Fresenius is selling 7.8 million shares of Fresenius Medical Care for approximately €300 million to increase strategic flexibility and fund growth platforms.

4 sources. https://clstr.news/cluster/fresenius-to-sell-300-million-in-fresenius-medical-care-shares

---
Cite as: Fresenius share sale and capital allocation. CLSTR, https://clstr.news/situations/fresenius-share-sale-and-capital-allocation